Infinity Pharmaceuticals, Inc. Interest Expense on Debt
Infinity Pharmaceuticals, Inc. reported Interest Expense on Debt of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-04.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2016-05-04
- Infinity Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. interest expense, debt for fiscal 2015 was $600.00K, a 93.75% decline from fiscal 2014.
- Infinity Pharmaceuticals, Inc. interest expense, debt for fiscal 2014 was $9.60M.
- Infinity Pharmaceuticals, Inc. interest expense, debt for fiscal 2012 was $1.90M, a 850.00% increase from fiscal 2011.
- Infinity Pharmaceuticals, Inc. interest expense, debt for fiscal 2011 was $200.00K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $0.00 derived: sum of 2 quarters · filed 2016-05-04 | $0.00 derived: sum of 3 quarters · filed 2016-05-04 | $0.00 derived: sum of 4 quarters · filed 2016-05-04 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-23 | $600.00K 10-K · filed 2016-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $600.00K 10-Q · filed 2015-11-05 | $1.60M derived: sum of 4 quarters · filed 2016-05-04 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | $600.00K 10-Q · filed 2015-08-06 | $1.60M derived: sum of 3 quarters · filed 2016-05-04 | $6.10M derived: sum of 4 quarters · filed 2016-05-04 |
| 2015-03-31 | $600.00K 10-Q · filed 2016-05-04 | $1.60M derived: sum of 2 quarters · filed 2016-05-04 | $6.10M derived: sum of 3 quarters · filed 2016-05-04 | $9.00M derived: sum of 4 quarters · filed 2016-05-04 |
| 2014-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $5.50M derived: sum of 2 quarters · filed 2016-02-23 | $8.40M derived: sum of 3 quarters · filed 2016-02-23 | $9.60M 10-K · filed 2016-02-23 |
| 2014-09-30 | $4.50M 10-Q · filed 2014-11-10 | $7.40M derived: sum of 2 quarters · filed 2014-11-10 | $8.60M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.90M 10-Q · filed 2014-08-11 | $4.10M 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $1.10M 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $500.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.20M derived: sum of 3 quarters · filed 2014-02-25 | $1.90M 10-K · filed 2014-02-25 |
| 2012-09-30 | $500.00K 10-Q · filed 2013-11-07 | $1.20M derived: sum of 2 quarters · filed 2013-11-07 | $1.90M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $700.00K 10-Q · filed 2013-08-08 | $1.40M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $700.00K 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | $200.00K 10-K · filed 2014-02-25 |